Cecilia Low Wang, MD
Professor, Medicine-Endocrinology/Metabolism/Diabetes

Photo
Download CV
Medical School:
  • MD, University of Rochester School of Medicine and Dentistry (1996)
Undergraduate School:
  • BA, Pomona College (1991)
Internship:
  • University of Utah Medical Center Program (1997)
Residency:
  • University of Utah Medical Center Program, Chief Resident, Internal Medicine (2000)
Fellowships:
  • University of Colorado, Endocrinology, Diabetes and Metabolism (2003)
Languages: Mandarin, English
Department: Medicine-Endocrinology/Metabolism/Diabetes

Professional Titles

  • Director, Glucose Management Team, UCH
  • Clinician-Scientist, CPC Clinical Research
  • Program Director, CU Diabetes Fellowship Training Program

Research Interests

I study how diabetes and cardiovascular disease interact to cause problems for people with diabetes, and how best to prevent it and take care of it. I also study high blood sugars due to diabetes or to stress in the hospital and how best to manage it while keeping people safe (such as avoiding blood sugars that are too low).

Teaching

  • Professor of Medicine (2019)
    School of Medicine, Medicine
    Diabetes and cardiovascular disease, hospital dysglycemia, clinical trials, insulin resistance.

Publications

  • Shubrook JH, Ramirez BF, Healy AM, Salzberg L, Ahmed S, Feinberg H, Schutta M, Schwartz FL, Low Wang CC. Primary Care Diabetes Fellowship Programs: Developing National Standards. Clin Diabetes. 2021 Jan;39(1):88-96. PubMed PMID: 33551558
  • Seggelke SA, Ingram CC, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes. 2021 Apr;39(2):228-232. PubMed PMID: 33986579
  • Seggelke SA, Ingram CI, Crawley S, Low Wang CC. Insulin Resistance in a Hospitalized COVID-19 Patient: A Case Review. Clin Diabetes published online Dec 22, 2020. https://doi.org/10.2337/cd20-0036.
  • Low Wang CC. Commentary for www.PracticeUpdate.com on Diabetes Care article: A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial. PracticeUpdate website. Available at: https://www.practiceupdate.com/content/comparing-glargine-u300-and-glargine-u100-for-the-inpatient-management-of-patients-with-type-2-diabetes/98993/65/8/1. Accessed April 29, 2020
  • Behan S, Low Wang CC, Hess C, Mulder H, Gutierrez A, Fowkes F, Baumgartner I, Berger J, Katona B, Mahaffey K, Norgren L, Blomster J, Jones S, Patel MR, Hiatt WR, Bonaca MP. Polyvascular disease with and without diabetes and the risk of adverse cardiovascular and limb events in the EUCLID trial. J Am Coll Cardiol 2020. 40. Vascular medicine: Non coronary arterial disease. 20-A-14515-ACC.
  • Mayson SE, Haugen B, Low Wang CC. The Endocrinology Fellowship Thyroid/Neck Ultrasound Curriculum Innovations Project. 2020 AME Education Symposium. University of Colorado Anschutz Medical Campus, Aurora, CO.
  • Zaman A, McDermott MT, Mansfield V, Low Wang CC. Mortality in Patients with Glucose Derangements after ICU Admission. American Diabetes Association’s 80th Scientific Sessions 2020 Virtual. 1611-P in category 16-F Epidemiology—Other.
  • Govsyeyev N, Nehler MR, Low Wang CC, Kavanagh S, Hiatt WR, Long C, Jones WS, Fowkes FG, Berger JS, Patel MR, Katona B, Norgren L and Bonaca MP. Amputation in Patients With PAD With and Without Diabetes: Insights From the EUCLID Trial. American Heart Association Scientific Sessions 2020 Virtual. Circulation 2020;142(Suppl_3):Abstract 16512.
  • Low Wang CC, Everett BM, Burman KD, Wilson PWF. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs?. Circulation. 2019 Apr 2;139(14):1741-1743. PubMed PMID: 30933621
  • Hess CN, Low Wang CC, Hiatt WR. PCSK9 Inhibitors: Mechanisms of Action, Metabolic Effects, and Clinical Outcomes. Annu Rev Med. 2018 Jan 29;69:133-145. PubMed PMID: 29095667
  • Rogers RK, Hiatt WR, Patel MR, Shishehbor MH, White R, Khan ND, Bhalla NP, Jones WS, Low Wang CC. Ticagrelor in Peripheral Artery Disease Endovascular Revascularization (TI-PAD): Challenges in clinical trial execution. Vasc Med. 2018 Dec;23(6):513-522. PubMed PMID: 29629845
  • Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR. Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. J Am Coll Cardiol. 2018 Dec 25;72(25):3274-3284. PubMed PMID: 30573030
  • Wang YJ, Seggelke S, Hawkins RM, Gibbs J, Lindsay M, Hazlett I, Low Wang CC, Rasouli N, Young KA, Draznin B. IMPACT OF GLUCOSE MANAGEMENT TEAM ON OUTCOMES OF HOSPITALIZARON IN PATIENTS WITH TYPE 2 DIABETES ADMITTED TO THE MEDICAL SERVICE. Endocr Pract. 2016 Dec;22(12):1401-1405. PubMed PMID: 27540884
  • Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations. Circulation. 2016 Jun 14;133(24):2459-502. PubMed PMID: 27297342
  • Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
  • Draznin B, Wang Y, Seggelke S, Hawkins RM, Gibbs J, Bridenstine M, Rasouli N, Wang CL. Glycemic control and outcomes of hospitalization in noncritically ill patients with type 2 diabetes admitted with cardiac problems or infections. Endocr Pract. 2014 Dec;20(12):1303-8. PubMed PMID: 25100383
  • Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang C, Draznin B. Transitional care clinic for uninsured and medicaid-covered patients with diabetes mellitus discharged from the hospital: a pilot quality improvement study. Hosp Pract (1995). 2014 Feb;42(1):46-51. PubMed PMID: 24566596
  • Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Wang CC, Draznin B. Effect of glargine insulin delivery method (pen device versus vial/syringe) on glycemic control and patient preferences in patients with type 1 and type 2 diabetes. Endocr Pract. 2014 Jun;20(6):536-9. PubMed PMID: 24326004
  • Wang CC, Adochio RL, Leitner JW, Abeyta IM, Draznin B, Cornier MA. Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism. 2013 Apr;62(4):595-603. PubMed PMID: 23174405
  • Low Wang CC, Lu L, Leitner JW, Sarraf M, Gianani R, Draznin B, Greyson CR, Reusch JE, Schwartz GG. Arterial insulin resistance in Yucatan micropigs with diet-induced obesity and metabolic syndrome. J Diabetes Complications. 2013 Jul-Aug;27(4):307-15. PubMed PMID: 23558108
  • Low Wang CC, Draznin B. Practical approach to management of inpatient hyperglycemia in select patient populations. Hosp Pract (1995). 2013 Apr;41(2):45-53. PubMed PMID: 23680736
  • Draznin B, Gilden J, Golden SH, Inzucchi SE, PRIDE investigators, Baldwin D, Bode BW, Boord JB, Braithwaite SS, Cagliero E, Dungan KM, Falciglia M, Figaro MK, Hirsch IB, Klonoff D, Korytkowski MT, Kosiborod M, Lien LF, Magee MF, Masharani U, Maynard G, McDonnell ME, Moghissi ES, Rasouli N, Rubin DJ, Rushakoff RJ, Sadhu AR, Schwartz S, Seley JJ, Umpierrez GE, Vigersky RA, Low CC, Wexler DJ. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care. 2013 Jul;36(7):1807-14. PubMed PMID: 23801791
  • Seggelke SA, Hawkins RM, Gibbs J, Rasouli N, Low CC, Draznin B. Effect of Glargine Insulin Delivery Method (Pen-Device vs. Vial-Syringe) on Glycemic Control and Patient Preferences in Patients with Type 1 and Type 2 Diabetes. Endocr Pract. 2013 Dec 10;:1-12. [Epub ahead of print] PubMed PMID: 24326004
  • Draznin B, Gilden J, Golden SH, Inzucchi S, PRIDE Investigators. Response to comment on: Draznin et al. Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care 2013;36:1807-1814. Diabetes Care. 2013 Dec;36(12):e220. PubMed PMID: 24265389
View All (24 Total) View Less

Professional Memberships

  • The Endocrine Society, Committee Member
  • American Diabetes Association, Member
  • American College of Physicians (ACP), Fellow
  • American Association of Clinical Endocrinology, Chair, Diabetes Disease State Network

Practice Locations

University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

Endocrinology/Diabetes/Metabolism - Anschutz
1635 Aurora Ct
6th Floor
Aurora, CO 80045
720-848-2650

Hospital Affiliation
  • University of Colorado Hospital

Specialty Information

Specialties
  • Endocrinology, Diabetes and Metabolism, Board Certification (2002, 2012)
  • Internal Medicine, Board Certification (2000)
Conditions & Treatments
  • Endocrine System (Hormones)
  • Food, Nutrition and Metabolism - Nutrition
  • Food, Nutrition and Metabolism - Weight Loss and Dieting
  • Wellness and Lifestyle - Exercise and Physical Fitness
  • Endocrine System (Hormones) - Adult Type 1 Diabetes
  • Endocrine System (Hormones) - Adult Type 2 Diabetes
  • Endocrine System (Hormones) - Thyroid Disease
  • Heart and Circulation - Heart Diseases - Prevention
  • Food, Nutrition and Metabolism
  • Heart and Circulation
  • Wellness and Lifestyle
  • Food, Nutrition and Metabolism - Obesity
Clinical Interests
I mainly focus on evaluation and management of dysglycemia, particularly type 1 and type 2 Diabetes Mellitus, other forms of diabetes, insulin resistance, nutrition, pre-diabetes, vitamin D deficiency, and thyroid dysfunction.

Care Philosophy
I do my best to leverage my expertise and experience to help people achieve and maintain health, particularly as it relates to endocrine/metabolic disorders. In order to accomplish this, I work with each of my patients to create a plan for evaluation (if needed) and treatment. I consider it a privilege to do what I do and to have people entrust their endocrine care to me. My goal is always to have a thoughtful dialogue and personalize each individual’s care to achieve their personal wellness goals.

Personal Interests
I love being outdoors - cycling, skiing, running, and hiking. Other things I spend my time on: books, food, travel, and music.

Public Speaking
Yes
I speak to specialists, primary care, and the lay community about all aspects of diabetes care, especially diabetes and cardiovascular disease, and inpatient hyperglycemia (diabetes, stress hyperglycemia). I also speak to primary care audiences about obesity, osteoporosis, and thyroid disorders.

General Information

Medical Schools:
  • MD, University of Rochester School of Medicine and Dentistry (1996)
Undergraduate Schools:
  • BA, Pomona College (1991)
Internships:
  • University of Utah Medical Center Program (1997)
Residency Programs:
  • University of Utah Medical Center Program, Chief Resident, Internal Medicine (2000)
Fellowships:
  • University of Colorado, Endocrinology, Diabetes and Metabolism (2003)
Download CV
Languages: Mandarin, English
Department: Medicine-Endocrinology/Metabolism/Diabetes
;